Tony Tian

Growth Stage Tech Investment

📍 Cambridge, Massachusetts, United States🔄 Updated September 2026💼 8 investments📅 11 years investing🗓 Last invested Jul 2019𝕏 @upgrade_to_unlock
VC🌍 United States
8
Total investments
3
Early stage
1
Mid stage
0
Late stage
11y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2019
First-in-class technology-forward eco-friendly aluminum mill, proudly creating 1500 new jobs for Eastern Kentucky and serving the growing needs of the automotive and aerospace industries.
early stageMining & Metals
Investor
Nov 2018
We are group of rocket scientists, serial entrepreneurs, engineers, cyclists, inventors, designers, and marketeers on a mission to fix the future. You can learn more about us and our wheels on our website. By incorporating the entire powertrain into the wheel itself we created a wheel turns any bicycle into an electric vehicle in under 60 seconds.
mid stageManufacturing
Investor
Mar 2017
Neural Galaxy, a global leading brain science company. Jointly founded in July 2019 by Professor Hesheng Liu of Harvard Medical School, Guoping Feng and Robert Desimone at MIT, and Mr. Coach Wei. Neural Galaxy's mission is to solve brain disorders. Neural Galaxy announced its $6.2M Angel round financing and over $15M Pre-A round financing. With plus rounds and the A round financing over $75M, the startup has raised more than approximate $100M. Neural Galaxy has successfully solved a significant neuroscience challenge. It has developed the world's first and the only “personalized Brain Functional Sectors” technology (pBFS), reliably and accurately mapping over 200 functional parcellations of an individual brain. In 2020, Neural Galaxy released the world's first "Personalized Brain Computing Platform", enabling doctors to investigate individual-level brain functional issues from observing neural circuits and neural networks clinically for the first time. Its innovative therapy, POINT therapy, achieved individual-level precise intervention of brain disorder with a non-invasive "brain-computer interaction" approach to read, decode and write brain signals. Neural Galaxy has achieved significant positive treatment outcomes in several major brain diseases such as Depression, Alzheimer's disease, Parkinson's disease, Autism, and Aphasia through clinical trials jointly carried out with several top-tier hospitals.
Investor
Aug 2016
LogicInk is developing a wellbeing sensor platform. A series of bio-chemical signals that can be worn daily, to support your wellbeing with increased knowledge about your health and daily peace of mind – from UV exposure and particles in the air we breathe, to the diverse microbiome that permeates our skin through the surfaces we touch.
Investor
Jan 2015
When we look at the way TV has always been measured - a lot is missing from the equation: Who’s actually in the room, and are their eyes even on the screen? TVision is the leader in TV performance metrics - an advertising technology firm that delivers real-time performance metrics for marketing effectiveness and efficiency. We use cutting edge technology to measure what was once unmeasurable - how people really watch TV. We’re a venture-backed company, deeply immersed in the intersection of data, media, and advertising. TVision enables the media industry - brands, networks, and data partners alike - to reduce waste and drive greater marketing results. We’re based in New York City, the advertising and media capital of the world.
Investor
Jan 2015
en-Gauge is a safety technology company offering innovative solutions for building safety monitoring. Developed by pioneers in the fire safety business, the en-Gauge fire extinguisher monitoring system is the only monitoring system that remotely protects installed fire suppression equipment and extinguishers from theft, vandalism or malfunction. en-Gauge has deployed its patented monitoring system in airports, college campuses, businesses and government facilities throughout the country.
Experience · 10 entries
All (10)
Investments (8)
2019
Investor
Jul 2019
First-in-class technology-forward eco-friendly aluminum mill, proudly creating 1500 new jobs for Eastern Kentucky and serving the growing needs of the automotive and aerospace industries.
early stageMining & Metals
2018
Investor
Nov 2018
We are group of rocket scientists, serial entrepreneurs, engineers, cyclists, inventors, designers, and marketeers on a mission to fix the future. You can learn more about us and our wheels on our website. By incorporating the entire powertrain into the wheel itself we created a wheel turns any bicycle into an electric vehicle in under 60 seconds.
mid stageManufacturing
Huaxu Fund
Venture Partner
Jun 2018
2017
Neuro Galaxy Inc
Investor
Mar 2017
Investor
Mar 2017
Neural Galaxy, a global leading brain science company. Jointly founded in July 2019 by Professor Hesheng Liu of Harvard Medical School, Guoping Feng and Robert Desimone at MIT, and Mr. Coach Wei. Neural Galaxy's mission is to solve brain disorders. Neural Galaxy announced its $6.2M Angel round financing and over $15M Pre-A round financing. With plus rounds and the A round financing over $75M, the startup has raised more than approximate $100M. Neural Galaxy has successfully solved a significant neuroscience challenge. It has developed the world's first and the only “personalized Brain Functional Sectors” technology (pBFS), reliably and accurately mapping over 200 functional parcellations of an individual brain. In 2020, Neural Galaxy released the world's first "Personalized Brain Computing Platform", enabling doctors to investigate individual-level brain functional issues from observing neural circuits and neural networks clinically for the first time. Its innovative therapy, POINT therapy, achieved individual-level precise intervention of brain disorder with a non-invasive "brain-computer interaction" approach to read, decode and write brain signals. Neural Galaxy has achieved significant positive treatment outcomes in several major brain diseases such as Depression, Alzheimer's disease, Parkinson's disease, Autism, and Aphasia through clinical trials jointly carried out with several top-tier hospitals.
Show all 10 entries ↓
Investment activity
2015–2019 · 8 investments
2015320161201722018120191
Recent (last 2 years)Earlier